Deutsche Bank Starts Salix Pharmaceuticals (SLXP) at Hold
Tweet Send to a Friend
Deutsche Bank initiated coverage on Salix Pharmaceuticals (NASDAQ: SLXP) with a Hold rating and a price target of $139.00."Salix is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE